Brazil Approves Import of China’s Sinovac Vaccine

Brazil Approves Import of China’s Sinovac Vaccine

Brazil’s health regulator authorized the import of a Chinese-produced vaccine after claims from President Jair Bolsonaro that the country lacked the creditability to develop a cure for the coronavirus.

The Butantan Institute, a Sao Paulo research center that has partnered with Sinovac Biotech Ltd, was granted an “exceptional” permission to bring six million doses of the unregistered Coronavac drug into the country for phase three trials, the Brazilian Health Surveillance Agency, or Anvisa, said in a statement Friday afternoon.

The trial has become the latest flash point in the fight between local leadership and Bolsonaro over the handling of the outbreak. The president said earlier this week that his government would not purchase the drug due “to its origin.”